Skip to content

Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' .

Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' (EXCAP-hEAT) Among Breast Cancer Survivors Receiving Adjuvant Endocrine Therapy.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07529353
Acronym
EXCAP-hEAT
Enrollment
20
Registered
2026-04-14
Start date
2026-10-01
Completion date
2028-10-01
Last updated
2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Cancer Related Fatigue

Keywords

Breast Cancer Survivorship, Home Based Exercise, Fatigue Management

Brief summary

This study evaluates the feasibility and preliminary effects of a home based exercise and activity program for individuals with cancer. Participants will engage in a structured intervention designed to support physical activity and symptom management. The study will assess changes in patient reported outcomes, functional measures, and overall adherence to the program. Findings will help determine whether this approach is practical and potentially beneficial for improving health related outcomes in this population.

Interventions

BEHAVIORALEXCAP Exercise Program

Home-based walking prescription with progressive 5% weekly step increase and resistance band training performed at least twice per week over 6 weeks.

BEHAVIORAL10-Hour Healthy Eating Timeframe (hEAT)

Participants will self-select and maintain a daily eating window of 10 hours or less for 6 weeks, with timing of first and last meals recorded daily.

Sponsors

University of Rochester
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Must be aged 18 years or older * Must have a confirmed diagnosis of breast cancer (stage I-IIIC) * Must have completed adjuvant chemotherapy, surgery, and/or radiation for cancer at least 2 - 120 months prior to enrolling, * Must be prescribed adjuvant endocrine therapy, * Must have a baseline level of fatigue, as determined by reporting a score of 4 or higher on the Symptom Inventory * Must have a body mass index greater than or equal to 25 kg per meter squared * Must have the ability to ambulate independently * Must be willing and able to participate in home-based exercise and eating timeframe intervention * Must have the ability to read and understand the English language,

Exclusion criteria

* Must not have metastatic or recurrent breast cancer * Must not be currently receiving chemotherapy or radiation therapy * Must not have a medical condition that would preclude safe participation in intervention or study procedures * Must not be pregnant, or planning to become pregnant during the study period * Must not be in the active or maintenance stage of exercise behavior as assessed by the Exercise Stages of Change Short Form, * Must not have any condition that in the opinion of the investigator would interfere with participation or safety * Must not be currently using, or plan to initiate use of prescription or over-the-counter weight-loss medications

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Participants Meeting Pre-Specified Adherence CriteriaBaseline to Day 42Percentage of participants who meet all three adherence criteria during the 6-week intervention: Maintain a ≤10-hour eating timeframe on at least 50 percent of intervention days (21 of 42 days) Complete resistance band exercises at least 12 total sessions during the 6-week period Increase average weekly step count by at least 20 percent from baseline to Week 6

Secondary

MeasureTime frameDescription
Mean Change in Brief Fatigue Inventory Total ScoreBaseline to Day 42Mean difference in total BFI score from baseline (Day 0) to post-intervention (Day 42). Higher scores indicate greater fatigue.
Mean Change in Multidimensional Fatigue Symptom Inventory Total ScoreBaseline to Day 42Mean difference in total MFSI score from baseline (Day 0) to post-intervention (Day 42). Higher scores indicate greater fatigue burden.
Mean Change in Body Mass IndexBaseline to Day 42Mean difference in BMI (kg/m²) measured at baseline and at Day 42.
Mean Change in 30-Second Bicep Curl Test RepetitionsBaseline to Day 42Mean difference in total number of completed bicep curl repetitions within 30 seconds from baseline to Day 42.
Mean Change in 30-Second Chair Stand Test RepetitionsBaseline to Day 42Mean difference in total number of completed chair stands within 30 seconds from baseline to Day 42.
Mean Change in Estimated Submaximal VO2Baseline to Day 42Mean difference in estimated VO2submax (mL/kg/min) obtained from treadmill testing at baseline and Day 42.

Countries

United States

Contacts

CONTACTLindsey Mattick, PhD
Lindsey_Mattick@urmc.rochester.edu5852740473
PRINCIPAL_INVESTIGATORLindsey Mattick, PhD

University of Rochester

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 18, 2026